Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 460 participants.

Also called NCT00737152

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 460 participants (planned count) (from the registry)
Sponsor
American Scitech International (from the registry)
Registry
  • NCT NCT00737152
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, India (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT00737152. Non-randomized; no masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2014-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus
Acronym
ASI-DMII
Condition
Type II Diabetes Mellitus
Intervention (Other)
RAS 130 with diet and exercise
Lead sponsor
American Scitech International (class: other)
Collaborator
Proactive Clinical Research (class: not stated)

Record details

Record id
cardio:ct-nct00737152
Content hash
2e3f0594153c0a94ed73a61fd6a63f3e3a0689ebf1266c13678b30dad5424d3a